This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Opal, S. M. Articles by Morrison, D. C. Search for Related Content PubMed PubMed Citation Articles by Opal, S. M. Articles by Morrison, D. C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Sepsis Social Bookmarking                         What's this?

Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis

Brown University School of Medicine, Infectious Disease Division, Memorial Hospital of Rhode Island, Pawtucket, Rhode Island, USA, Steven_Opal{at}brown.edu

John E. Palardy

Brown University School of Medicine, Infectious Disease Division, Memorial Hospital of Rhode Island, Pawtucket, Rhode Island, USA

Nicolas Parejo

Brown University School of Medicine, Infectious Disease Division, Memorial Hospital of Rhode Island, Pawtucket, Rhode Island, USA

David C. Morrison

Office of Research Administration, Saint Luke's Hospital, Kansas City, Missouri, USA

Lipopolyamines are a class of polycationic amphiphilic compounds that have been shown to bind with high affinity to polyanionic macromolecules, including both DNA and bacterial lipopolysaccharide (LPS). One of these compounds, termed DOSPER (1,3-di-oleoyloxy-2-(6-carboxylspermyl)-propylamide), is non-cytotoxic and has been shown to inhibit LPS-mediated cytokine release and lethality in endotoxin challenge models. In the study reported here, the activity of DOSPER was tested in neutropenic rats with invasive Gram-negative bacteremia caused by Pseudomonas aeruginosa. DOSPER alone was ineffective (0/8) at influencing mortality, but provided a significant survival advantage if administered in combination with a bactericidal antibiotic, ceftazidime (10/12; P <0.05). Ceftazidime alone was partially protective (6/12) while the control group had no survivors (0/8). DOSPER administration markedly reduced circulating endotoxin levels (P <0.01) and interleukin-6 levels (P <0.05) but had no significant effect on bacteremia and bacterial concentrations of P. aeruginosa in liver or spleen tissue. Lipopolyamines may be potentially valuable as a therapeutic adjunct in treatment of Gram-negative bacterial sepsis.

Journal of Endotoxin Research, Vol. 7, No. 1, 35-38 (2001)
DOI: 10.1177/09680519010070010501


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?